Companies

Greenwich LifeSciences, Inc.

GLSI · CIK 0001799788 · operating

$27.68-0.16%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$379.48M
P/E
Fwd P/E-33.40
PEG
P/S
P/B173.35
EV/EBITDA-19.18
EV/Rev

Profitability

Gross Margin
Op. Margin
Net Margin
ROE-623.07%
ROA-385.68%
FCF Margin

Financial Health

Current Ratio
Debt/Equity0.62
Free Cash Flow-$7.27M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth-75.36%
Beta1.49
52W High$34.1
52W Low$7.78

About Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc. (GLSI) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $384 million, Greenwich LifeSciences, Inc. is a small-cap company. The stock currently trades at $27.68, down 0.16% today, with a 52-week range of $7.78–$34.10.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-1.21$-1.21-75.4%
2023$-0.69$-0.69-13.1%
2022$-0.61
2021
2020

Annual Reports (10-K) · 5 filings

Report DateFiledAccession Number
2024-12-312025-04-150001641172-25-004819SEC ↗
2023-12-312024-04-150001493152-24-014625SEC ↗
2022-12-312023-03-310001493152-23-010284SEC ↗
2021-12-312022-03-210001493152-22-007377SEC ↗
2020-12-312021-03-310001493152-21-007532SEC ↗